Dermatotoxicology of microneedles (MNs) in man.

Contact dermatitis Dermatotoxicology Hyperpigmentation Infection Microneedles Skin

Journal

Biomedical microdevices
ISSN: 1572-8781
Titre abrégé: Biomed Microdevices
Pays: United States
ID NLM: 100887374

Informations de publication

Date de publication:
04 07 2019
Historique:
entrez: 6 7 2019
pubmed: 6 7 2019
medline: 6 2 2020
Statut: epublish

Résumé

Developed within the last few decades, microneedles (MNs) have only recently seen wide-scale use among the general population, especially in the area of cosmetics. With the FDA only starting to regulate microneedling devices and the many new microneedling products that enter the modern global market, it is of utmost importance to establish the safety profile and reasonable expectations of the microneedling practice and its products. In our review of current literature, the authors searched the keyword "microneedle" with the following terms: "safety", "side effect", "toxicology", "adverse effect", "adverse event", "infection", "dermatitis", "granuloma", "scarring", and "hyperpigmentation". Despite wide-scale implementation of MNs, we are likely only beginning to understand the potential of MNs as a medical and consumer product, and we should, therefore, be aware of any potential adverse events associated with the product.

Identifiants

pubmed: 31273476
doi: 10.1007/s10544-019-0371-3
pii: 10.1007/s10544-019-0371-3
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

66

Auteurs

John Havens Cary (JH)

Louisiana State University School of Medicine, 433 Bolivar Street, New Orleans, LA, 70112, USA. John.Cary@ucsf.edu.

Becky S Li (BS)

Howard University College of Medicine, 520 W Street NW, Washington, DC, 20059, USA. Becky.Li@ucsf.edu.

Howard I Maibach (HI)

School of Medicine, Department of Dermatology, University of California, San Francisco, 90 Medical Center Way, Box 0989, Surge Building, Room 110, San Francisco, CA, 94143-0989, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH